A study to evaluate the effect of a digital disease management tool in patients with type 2 diabetes mellitus

Trial Identifier: D1841C00002
Sponsor: AstraZeneca Pharmaceuticals
Collaborator:
PAREXEL
NCTID:: NCT02749435
Start Date: May 2016
Primary Completion Date: October 2016
Condition: Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
United Kingdom, Angus Dundee, Angus, United Kingdom
United Kingdom, Cardiff [Caerdydd GB-CRD] Cardiff, Cardiff [Caerdydd GB-CRD], United Kingdom
United Kingdom, Dundee City Muirhead, Dundee City, United Kingdom
United Kingdom, Fife Fife, United Kingdom
United Kingdom, Flintshire [Sir y Fflint GB-FF Flintshire, Flintshire [Sir y Fflint GB-FF, United Kingdom
United Kingdom, Harrow London, Harrow, United Kingdom
United Kingdom, Hertfordshire Middlesex, Hertfordshire, United Kingdom
United Kingdom, Lancashire Manchester, Lancashire, United Kingdom
United Kingdom, Leicester Leicester, United Kingdom
United Kingdom, London London, United Kingdom
United Kingdom, Manchester Oldham, Manchester, United Kingdom
United Kingdom, Mid Glamorgan Mid Glamorgan, United Kingdom
United Kingdom, Midlothian Bonnyrigg, Midlothian, United Kingdom
United Kingdom, Midlothian Edinburgh, Midlothian, United Kingdom
United Kingdom, Stockport Stockport, United Kingdom